2982 completed, 792 unknown, 504 recruiting, 390 terminated. 1377 Phase 2, 1148 Phase 1, 779 Phase 3, 762 Not applicable, 520 Phase 4.
Follow DNA Virus Infections: new trials by email Literature Review of DNA Virus Infections trials Research Report on DNA Virus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Assessment of Myocarditis After Replication-Deficient Smallpox Immunization JYNNEOS - Myopericarditis, Small Pox | Not yet recruiting | Womack Army Medical Center | 2350 | 2029-03-01 | 2023-12-14 | |
| Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines | Not applicable | Not yet recruiting | University of Florida | 1296 | 2027-09-15 | 2026-09-14 |
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 16 | 2027-04-17 | 2026-08-11 |
| Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI. CAR-T anti-CD19 COL01 - Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies | Phase 1 | Not yet recruiting | GUSTAVO SALGUERO | 12 | 2027-04-01 | 2026-10-20 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| Combating Related Epidemics in HCV Cepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2 - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV) | Phase 4 | Not yet recruiting | Duke University | 1280 | 2027-01-20 | 2026-10-15 |
| Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene Biopsy Procedure, Biospecimen Collection, Computed Tomography - Burkitt Lymphoma, Double-Expressor Lymphoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 50 | 2027-01-11 | 2026-10-14 |
| Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 52 | 2027-01-01 | 2026-09-14 |
| Study Of KITE-753 in R/R B-Cell ALL KITE-753 - B-cell Acute Lymphoblastic Leukemia | Phase 1 | Not yet recruiting | M.D. Anderson Cancer Center | 18 | 2026-12-31 | 2026-09-11 |
| Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young Adults MVA-BN-EBV, Placebo - Epstein Barr Virus (EBV) Infection | Phase 1 | Not yet recruiting | Bavarian Nordic | 15 | 2026-12-15 | 2026-10-22 |
| Targeting ANKRD11 Reverses HBV-Specific CD8+ T Cell Dysfunction and Tolerance Chronic Hepatitis B | Not yet recruiting | Beijing Municipal Administration of Hospitals | 40 | 2026-12-01 | 2026-08-28 | |
| Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia Rituximab - PTLD, Epstein Barr Virus (EBV) Infection | Phase 1 | Not yet recruiting | Jennifer Amengual | 28 | 2026-12-01 | 2026-09-17 |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study MB-CART19.1 - Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 30 | 2026-12-01 | 2026-10-22 |
| EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases Donor-derived ex-vivo expanded EBV Tscm CTL - EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) | Phase 1 / Phase 2 | Not yet recruiting | University Hospital, Basel, Switzerland | 10 | 2026-11-01 | 2025-03-03 |
| Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II Valganciclovir, Ganciclovir (GCV), Placebo - Cytomegalovirus (CMV), Anterior Uveitis | Phase 2 | Not yet recruiting | University of California, San Francisco | 117 | 2026-11-01 | 2026-08-11 |
| 25BT056: Basket Study of Viral Cytotoxic T Lymphocytes Virus-Specific Cytotoxic T Lymphocytes (vCTLs) - EBV Viremia, CMV Viremia | Early Phase 1 | Not yet recruiting | Children's Hospital of Philadelphia | 35 | 2026-11-01 | 2026-10-22 |
Showing 20 of 5348. Sign in to see all of them.
Hepatitis B (1000) · Burkitt Lymphoma (972) · Hepatitis B, Chronic (860) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (591) · Lymphoma, Large B-Cell, Diffuse (576) · Papillomavirus Infections (562) · Lymphoma, Follicular (525) · Lymphoma, Non-Hodgkin (515) · Lymphoma, Mantle-Cell (510) · Leukemia, Lymphocytic, Chronic, B-Cell (471) · Lymphoma (471) · Lymphoma, B-Cell, Marginal Zone (458) · Lymphoma, Large-Cell, Immunoblastic (445) · Cytomegalovirus Infections (369) · Hodgkin Disease (362)
Virus Diseases (5260) · Infections (5253) · Communicable Diseases (2657) · Pathological Conditions, Signs and Symptoms (2472) · Herpesviridae Infections (2393) · Pathologic Processes (2332) · Disease Attributes (2178) · Tumor Virus Infections (2025) · Blood-Borne Infections (2017) · Digestive System Diseases (1894) · Liver Diseases (1744) · Hepatitis, Viral, Human (1702) · Hepadnaviridae Infections (1698) · Neoplasms (1673)
Cyclophosphamide (240) · entecavir (198) · Tenofovir (168) · Rituximab (122) · Etoposide (112) · peginterferon alfa-2a (111) · Vincristine (102) · Filgrastim (98) · Methotrexate (97) · Peripheral Blood Stem Cell Transplantation (96) · Cytarabine (94) · fludarabine phosphate (91) · Doxorubicin (83) · Radiotherapy (80) · Hepatitis B Vaccines (78)
GlaxoSmithKline (327) · National Cancer Institute (NCI) (186) · National Institute of Allergy and Infectious Diseases (NIAID) (182) · Merck Sharp & Dohme LLC (129) · Hoffmann-La Roche (71) · Fred Hutchinson Cancer Center (66) · Gilead Sciences (54) · M.D. Anderson Cancer Center (44) · Bristol-Myers Squibb (42) · Sanofi Pasteur, a Sanofi Company (40) · Third Affiliated Hospital, Sun Yat-Sen University (39) · Memorial Sloan Kettering Cancer Center (38) · National Taiwan University Hospital (38) · University of Washington (38) · Assistance Publique - Hôpitaux de Paris (35)
United States (2118) · China (840) · France (326) · Canada (312) · South Korea (267) · Germany (240) · United Kingdom (233) · Italy (210) · Taiwan (204) · Australia (200) · Spain (199) · Belgium (156) · Hong Kong (133) · Thailand (122) · New Zealand (120)
Liang Peng, Doctor (13) · Robert Yarchoan, M.D. (11) · Ajay Gopal (9) · Anna Wald, MD, MPH (9) · Ramya M Ramaswami, M.D. (8) · Elias Jabbour (7) · Helen E Heslop, MD (7) · Marc G Ghany, M.D. (7)
PMID 41276263, PMID 41671463, PMID 37781954, PMID 38700045, PMID 39807668, PMID 35622074, PMID 28427875, PMID 34515338, PMID 27422279, PMID 32499241, PMID 19052126, PMID 19935017, PMID 32184277, PMID 24915612, PMID 28404091, PMID 28404092, PMID 29405329, PMID 31824976, PMID 33460002, PMID 35599306, PMID 36263798, PMID 15470215, PMID 19187608, PMID 19236277, PMID 19236279, PMID 21182232, PMID 22225814, PMID 22436845, PMID 23046671, PMID 23518903, PMID 24731816, PMID 25424785, PMID 25424918, PMID 25987775, PMID 27658343, PMID 29074187, PMID 29211620, PMID 30982556, PMID 31042791, PMID 32589970, PMID 32710245, PMID 33857679, PMID 35149535, PMID 35941076, PMID 36066965, PMID 37166199, PMID 38551807, PMID 40237463, PMID 40396505, PMID 41166720
P30CA015704 (26), P30CA033572 (25), 2016 (21), 2017 (21), 2023 (20), P30CA043703 (19), 2018 (18), 2019 (18), U01CA121947 (18), 2014 (17), U10CA032102 (17), 2009 (15), P30CA006973 (14), 2015 (13), P30CA015083 (12)